AERI
Aerie Pharmaceuticals Inc
Price:  
15.25 
USD
Volume:  
1,206,402.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Aerie EV/EBITDA

-183.6%
Upside

As of 2024-05-30, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 20.8x - 22.9x 22.7x
Forward P/E multiples 20.3x - 23.8x 20.4x
Fair Price (12.48) - (13.24) (12.75)
Upside -181.9% - -186.8% -183.6%
15.25 USD
Stock Price
(12.75) USD
Fair Price

Aerie EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA